Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Global Synthetic Stem Cells Market, by Region, 2019-2027 (USD Billion)
1.2.2. Global Synthetic Stem Cells Market, by Application, 2019-2027 (USD Billion)
1.2.3. Global Synthetic Stem Cells Market, by End-Use, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Synthetic Stem Cells Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Synthetic Stem Cells Market Dynamics
3.1. Synthetic Stem Cells Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing incidences of various cardiovascular diseases
3.1.1.2. Government investment in research & development activities
3.1.2. Market Challenges
3.1.2.1. Unclear and unstructured regulations
3.1.3. Market Opportunities
3.1.3.1. Development of stem cells for stem line banking
Chapter 4. Global Synthetic Stem Cells Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Synthetic Stem Cells Market, by Application
6.1. Market Snapshot
6.2. Global Synthetic Stem Cells Market by Application, Performance - Potential Analysis
6.3. Global Synthetic Stem Cells Market Estimates & Forecasts by Application, 2018-2027 (USD Billion)
6.4. Synthetic Stem Cells Market, Sub Segment Analysis
6.4.1. Cardiovascular Disease
6.4.2. Neurological Disorders
6.4.3. Cancer
6.4.4. Diabetes
6.4.5. Gastrointestinal
6.4.6. Musculoskeletal Disorder
Chapter 7. Global Synthetic Stem Cells Market, by End-Use
7.1. Market Snapshot
7.2. Global Synthetic Stem Cells Market by End-Use, Performance - Potential Analysis
7.3. Global Synthetic Stem Cells Market Estimates & Forecasts by End-Use, 2018-2027 (USD Billion)
7.4. Synthetic Stem Cells Market, Sub Segment Analysis
7.4.1. Hospitals and surgical centers
7.4.2. Academic institutes
7.4.3. Research laboratories
7.4.4. Pharmaceutical and biotechnology companies
7.4.5. Others
Chapter 8. Global Synthetic Stem Cells Market, Regional Analysis
8.1. Synthetic Stem Cells Market, Regional Market Snapshot
8.2. North America Synthetic Stem Cells Market
8.2.1. U.S. Synthetic Stem Cells Market
8.2.1.1. Application breakdown estimates & forecasts, 2018-2027
8.2.1.2. End-Use breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Synthetic Stem Cells Market
8.3. Europe Synthetic Stem Cells Market Snapshot
8.3.1. U.K. Synthetic Stem Cells Market
8.3.2. Germany Synthetic Stem Cells Market
8.3.3. France Synthetic Stem Cells Market
8.3.4. Spain Synthetic Stem Cells Market
8.3.5. Italy Synthetic Stem Cells Market
8.3.6. Rest of Europe Synthetic Stem Cells Market
8.4. Asia-Pacific Synthetic Stem Cells Market Snapshot
8.4.1. China Synthetic Stem Cells Market
8.4.2. India Synthetic Stem Cells Market
8.4.3. Japan Synthetic Stem Cells Market
8.4.4. Australia Synthetic Stem Cells Market
8.4.5. South Korea Synthetic Stem Cells Market
8.4.6. Rest of Asia Pacific Synthetic Stem Cells Market
8.5. Latin America Synthetic Stem Cells Market Snapshot
8.5.1. Brazil Synthetic Stem Cells Market
8.5.2. Mexico Synthetic Stem Cells Market
8.6. Rest of The World Synthetic Stem Cells Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Caladrius Biosciences
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Sangamo Therapeutics
9.2.3. Athersys
9.2.4. Pluristem Therapeutics
9.2.5. Cellular Biomedicine Group
9.2.6. Vericel
9.2.7. ThermoGenesis Corp.
9.2.8. Gamida Cell
9.2.9. TheraCell Inc.
9.2.10. VeraTech Biologics, LLc
9.2.11. Brainstorm Cell Therapeutics
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption